GRND
Neutral signalScored 2026-10-23 Drivers: trend, fundamentals. Moteurs : tendance, fondamentaux.
Research, not advice.
À propos
Grindr Inc.
- Nom
- Grindr Inc.
- Secteur
- Technology
- Industrie
- Software - Application
- Bourse
- NYSE
- Capitalisation
- $2.4B
- Employés
- 172
- PDG
- George Arison
- Site web
- https://www.grindr.com
- Marché
- ALKTALRMBRZEIEKCNP
Grindr Inc. runs an online social networking platform specifically designed for the LGBTQ demographic. Through this digital space, gay, bisexual, transgender, and queer individuals can interact, exchange experiences and media, and freely express their identities. The service is accessible both as a free, advertisement-supported offering and through a premium, subscriber-based membership. Founded in 2009, the company maintains its operations from West Hollywood, California.
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
VENTE TOTALE: 1 500 000 titres (~21 760 066,40 $ US)
- Insiders
- Zage George Raymond III
- Total bought
-
—
Avg buy (VWAP, 90d window) —
- Total sold
-
$21,158,929
Avg sell (VWAP, 90d window) $14.68 vs last close $13.68 (-6.8%)
Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.
$14,098,629 of that total is under a Rule 10b5-1 plan. It is shown here and left out of the score.
- Last activity
- 2026-10-19
- Liquidity
- Liquid $26,109,233/day · 20d vol
- Last synced
-
2026-10-24 22:33:37
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-10-19 | Zage George Raymond III | Sell · S | 150,000 | $13.87 | $2,080,500 | Form 4 |
| 2026-10-16 | Zage George Raymond III | Sell · S | 350,000 | $14.23 | $4,979,800 | Form 4 |
| 2026-10-14 | Katz Zachary | Sell · S · 10b5-1 | 15,227 | $15.23 | $231,907 | Form 4 |
| 2026-10-02 | Zage George Raymond III | Sell · S · 10b5-1 | 292,270 | $13.65 | $3,989,486 | Form 4 |
| 2026-10-01 | Zage George Raymond III | Sell · S · 10b5-1 | 2,000 | $15.65 | $31,300 | Form 4 |
| 2026-09-17 | Zage George Raymond III | Sell · S · 10b5-1 | 166,400 | $15.41 | $2,564,224 | Form 4 |
| 2026-09-16 | Zage George Raymond III | Sell · S · 10b5-1 | 333,600 | $15.62 | $5,210,832 | Form 4 |
| 2026-09-14 | Katz Zachary | Sell · S · 10b5-1 | 15,227 | $15.57 | $237,084 | Form 4 |
| 2026-08-31 | Balance Austin J | Sell · S · 10b5-1 | 89,638 | $15.46 | $1,385,803 | Form 4 |
| 2026-08-19 | Baer Daniel Brooks | Sell · S · 10b5-1 | 3,500 | $15.65 | $54,775 | Form 4 |
| 2026-08-17 | Katz Zachary | Sell · S · 10b5-1 | 10,172 | $15.83 | $161,023 | Form 4 |
| 2026-08-03 | Katz Zachary | Sell · S · 10b5-1 | 12,979 | $17.89 | $232,194 | Form 4 |
Sales marked 10b5-1 are scheduled in advance and don't count toward the Quorum score. Les ventes marquées 10b5-1 sont planifiées à l'avance et ne pèsent pas dans le score Quorum.
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Signal
Neutral signalScored 2026-10-23 Drivers: trend, fundamentals. Moteurs : tendance, fondamentaux.
GRND presents a compelling financial turnaround story in 2025 with strong liquidity (80) and improving fundamentals (85), supported by a strategic M&A catalyst into LGBTQ telehealth via the $250M PurposeMed acquisition.
The first sentence of the analysis written for GRND on 2026-10-23 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Pulls against a bullish reading. Selling cluster — sale value, no purchase value
- Narrative Unavailable or mixed. Stored narrative reading is in the neutral band
- Congress Unavailable or mixed. No purchase disclosures in the stored window
- Timing Pulls against a bullish reading. Close is more than 0.5 ATR under stored support
- Financial indicators Supports a bullish reading. Current ratio 1.96 · operating margin 29%
Suggested stop 12.87, nearest stored support minus 0.5 ATR(5.9% under the last close). Reward/risk to the next stored resistance is 0.05. Wait — that reward/risk is under 2. Research, not advice. Not an order.
Recent news
- 2026-10-19 Insider Selling: Grindr (NYSE:GRND) Insider Sells $231,907.21 in Stock Grindr Inc. (NYSE: GRND - Get Free Report) insider Zachary Katz sold 15,227 shares of the firm''s stock in a transaction dated Wednesday, October 14th. The stock was sold at an average price of $15.23, for a total value of $231,907.21. Following the completion of the sale, the insider directly owned 618,000 shares of the company''s
- 2026-10-12 2 Top Growth Stocks to Buy Hand Over Fist Right Now These businesses probably won''t stay small forever.
- 2026-10-04 Contrasting Getty Images (NYSE:GETY) & Grindr (NYSE:GRND) Grindr (NYSE: GRND - Get Free Report) and Getty Images (NYSE: GETY - Get Free Report) are both communication services companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, institutional ownership, profitability and earnings. Risk and Volatility Grindr has a beta of
- 2026-10-04 Grindr Buys PurposeMed for $250M, Launching Push Into PrEP Telehealth Grindr (NYSE: GRND) said it has agreed to acquire PurposeMed Inc., the parent company of Freddie, a Canadian telehealth provider of HIV pre-exposure prophylaxis, or PrEP, that is expanding in the United States. Chief Executive Officer George Arison described the transaction as the company''s first major step toward building "Grindr Health," a healthcare business centered initially
- 2026-10-03 Grindr Buys PurposeMed for $250M, Launching Push Into PrEP Telehealth Grindr NYSE: GRND said it has agreed to acquire PurposeMed Inc., the parent company of Freddie, a Canadian telehealth provider of HIV pre-exposure prophylaxis, or PrEP, that is expanding in the United States.
- 2026-10-01 Grindr is spending $250M to signal that it''s getting serious about LGBTQ healthcare Grindr is expanding its footprint in LGBTQ-focused healthcare with its first major acquisition. The dating app is paying $250 million for health startup Freddie, with the aim of fully integrating Freddie''s HIV-prevention telehealth and pharmacy capabilities into a broader Grindr Health offering.
- 2026-10-01 Grindr Inc. (GRND) M&A Call Transcript Grindr Inc. (GRND) M&A Call Transcript
- 2026-09-30 Grindr expands beyond dating with $250 million telehealth acquisition of PurposeMed Grindr said it is acquiring PurposeMed, the parent company of HIV prevention telehealth provider Freddie. The deal is worth $250 million and is expected to close in the fourth quarter.
- 2026-09-30 Grindr to Acquire Freddie, Expanding Access to HIV Prevention for Millions of Users LOS ANGELES--(BUSINESS WIRE)--Grindr Inc. (NYSE: GRND), the Global Gayborhood in Your Pocket™, today announced it has agreed to acquire PurposeMed Inc., the parent company of Freddie, a leading telehealth provider of PrEP and HIV prevention care, for $250 million in cash and stock. The transaction may include up to an additional $70 million in cash consideration based on the achievement of certain performance targets and is expected to close in Q4 2026, subject to applicable closing conditions.
- 2026-09-30 Grindr Agrees to Buy HIV-Prevention Telehealth Provider Freddie for $250 Million The gay dating-app''s first major acquisition reflects a broader expansion into the healthcare business.
Market snapshot
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 72.4% | 74.6% | 74.0% | 73.7% | 74.4% | |
| Ebit Margin | 31.0% | 27.2% | -2.2% | 16.2% | 17.1% | |
| Ebitda Margin | 33.0% | 32.1% | 8.2% | 35.4% | 46.8% | |
| Operating Profit Margin | 28.7% | 26.9% | 21.4% | 6.7% | 16.3% | |
| Pretax Profit Margin | 27.0% | -34.3% | -19.9% | -0.0% | 4.3% | |
| Continuous Operations Profit Margin | 21.5% | -38.0% | -21.5% | 0.4% | 3.5% | |
| Net Profit Margin | 21.5% | -38.0% | -21.5% | 0.4% | 3.5% | |
| Bottom Line Profit Margin | 21.5% | -38.0% | -21.5% | 0.4% | 3.5% | |
| Current Ratio | 1.955 | 1.725 | 1.183 | 0.698 | 1.469 | |
| Quick Ratio | 1.955 | 1.725 | 1.183 | 0.698 | 1.469 | |
| Solvency Ratio | 0.214 | -0.187 | -0.062 | 0.088 | 0.259 | |
| Cash Ratio | 1.025 | 0.872 | 0.455 | 0.141 | 0.528 | |
| Price To Earnings Ratio | 27.080 | -24.108 | -27.437 | 861.111 | 306.042 | |
| Price To Earnings Growth Ratio | -0.162 | -0.184 | 0.005 | -10.290 | -2.900 | |
| Forward Price To Earnings Growth Ratio | -0.162 | -0.184 | 0.005 | -10.290 | -2.900 | |
| Price To Earnings Diluted Ratio | 27.633 | -24.108 | -27.437 | 861.111 | 306.042 | |
| Price To Earnings Diluted Growth Ratio | -0.166 | -0.184 | 0.005 | -10.290 | -2.900 | |
| Price To Book Ratio | 54.647 | -23.848 | -83.600 | 181.183 | 5.881 | |
| Price To Sales Ratio | 5.839 | 9.104 | 5.889 | 3.765 | 10.615 | |
| Price To Free Cash Flow Ratio | 18.247 | 33.376 | 47.912 | 16.293 | 50.533 | |
| Price To Operating Cash Flow Ratio | 18.151 | 33.043 | 42.306 | 14.496 | 44.960 | |
| Debt To Assets Ratio | 0.754 | 0.613 | 0.774 | 0.833 | 0.305 | |
| Debt To Equity Ratio | 8.522 | -2.234 | -18.819 | 90.162 | 0.521 | |
| Debt To Capital Ratio | 0.895 | 1.810 | 1.056 | 0.989 | 0.342 | |
| Long Term Debt To Capital Ratio | 0.889 | 1.914 | 1.060 | 0.988 | 0.336 | |
| Financial Leverage Ratio | 11.297 | -3.641 | -24.305 | 108.299 | 1.708 | |
| Working Capital Turnover Ratio | 6.753 | 11.434 | -68.692 | -83.859 | -32.425 | |
| Operating Cash Flow Ratio | 1.666 | 1.400 | 0.596 | 0.819 | 1.152 | |
| Operating Cash Flow Sales Ratio | 0.322 | 0.276 | 0.139 | 0.260 | 0.236 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.995 | 0.990 | 0.883 | 0.890 | 0.890 | |
| Debt Service Coverage Ratio | 3.221 | 2.414 | 0.283 | 1.302 | 2.973 | |
| Interest Coverage Ratio | 7.158 | 3.615 | 1.205 | 0.413 | 1.268 | |
| Short Term Operating Cash Flow Coverage Ratio | 7.076 | 6.330 | 2.410 | 2.286 | 8.966 | |
| Operating Cash Flow Coverage Ratio | 0.353 | 0.323 | 0.105 | 0.139 | 0.251 | |
| Capital Expenditure Coverage Ratio | 189.702 | 100.484 | 8.545 | 9.068 | 9.068 | |
| Dividend Paid And Capex Coverage Ratio | 189.702 | 100.484 | 8.545 | 0.251 | 9.068 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 230.405 | 0.000 | |
| Enterprise Value Multiple | 19.862 | 30.450 | 86.648 | 15.800 | 24.465 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 72.4% | ▼-2.2% | ▼-1.4% |
| Ebit Margin | 31.0% | ▲3.7% | ▲13.1% |
| Ebitda Margin | 33.0% | ▲0.9% | ▲1.9% |
| Operating Profit Margin | 28.7% | ▲1.8% | ▲8.7% |
| Pretax Profit Margin | 27.0% | ▲61.3% | ▲31.6% |
| Continuous Operations Profit Margin | 21.5% | ▲59.6% | ▲28.3% |
| Net Profit Margin | 21.5% | ▲59.6% | ▲28.3% |
| Bottom Line Profit Margin | 21.5% | ▲59.6% | ▲28.3% |
| Current Ratio | 1.955 | ▲0.230 | ▲0.549 |
| Quick Ratio | 1.955 | ▲0.230 | ▲0.549 |
| Solvency Ratio | 0.214 | ▲0.401 | ▲0.152 |
| Cash Ratio | 1.025 | ▲0.153 | ▲0.421 |
| Price To Earnings Ratio | 27.080 | ▲51.188 | ▼-201.458 |
| Price To Earnings Growth Ratio | -0.162 | ▲0.022 | ▲2.545 |
| Forward Price To Earnings Growth Ratio | -0.162 | ▲0.022 | ▲2.545 |
| Price To Earnings Diluted Ratio | 27.633 | ▲51.741 | ▼-201.015 |
| Price To Earnings Diluted Growth Ratio | -0.166 | ▲0.017 | ▲2.541 |
| Price To Book Ratio | 54.647 | ▲78.495 | ▲27.794 |
| Price To Sales Ratio | 5.839 | ▼-3.265 | ▼-1.203 |
| Price To Free Cash Flow Ratio | 18.247 | ▼-15.128 | ▼-15.025 |
| Price To Operating Cash Flow Ratio | 18.151 | ▼-14.892 | ▼-12.440 |
| Debt To Assets Ratio | 0.754 | ▲0.141 | ▲0.098 |
| Debt To Equity Ratio | 8.522 | ▲10.756 | ▼-7.108 |
| Debt To Capital Ratio | 0.895 | ▼-0.915 | ▼-0.124 |
| Long Term Debt To Capital Ratio | 0.889 | ▼-1.025 | ▼-0.148 |
| Financial Leverage Ratio | 11.297 | ▲14.938 | ▼-7.375 |
| Working Capital Turnover Ratio | 6.753 | ▼-4.681 | ▲40.111 |
| Operating Cash Flow Ratio | 1.666 | ▲0.266 | ▲0.540 |
| Operating Cash Flow Sales Ratio | 0.322 | ▲0.046 | ▲0.075 |
| Free Cash Flow Operating Cash Flow Ratio | 0.995 | ▲0.005 | ▲0.065 |
| Debt Service Coverage Ratio | 3.221 | ▲0.807 | ▲1.183 |
| Interest Coverage Ratio | 7.158 | ▲3.543 | ▲4.426 |
| Short Term Operating Cash Flow Coverage Ratio | 7.076 | ▲0.745 | ▲1.662 |
| Operating Cash Flow Coverage Ratio | 0.353 | ▲0.030 | ▲0.119 |
| Capital Expenditure Coverage Ratio | 189.702 | ▲89.219 | ▲126.329 |
| Dividend Paid And Capex Coverage Ratio | 189.702 | ▲89.219 | ▲128.092 |
| Dividend Payout Ratio | 0.000 | 0.000 | ▼-46.081 |
| Enterprise Value Multiple | 19.862 | ▼-10.588 | ▼-15.583 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $2.57B | $3.14B | $1.53B | $734.2M | $1.55B | |
| Enterprise value | $2.88B | $3.37B | $1.85B | $1.09B | $1.67B | |
| EV / Sales | 6.55x | 9.79x | 7.11x | 5.59x | 11.45x | |
| EV / Op. cash flow | 20.37x | 35.52x | 51.06x | 21.54x | 48.48x | |
| EV / Free cash flow | 20.48x | 35.87x | 57.83x | 24.21x | 54.49x | |
| EV / EBITDA | 19.86x | 30.45x | 86.65x | 15.80x | 24.46x | |
| Net debt / EBITDA | 2.16x | 2.12x | 14.86x | 5.17x | 1.78x | |
| Current ratio | 1.96x | 1.73x | 1.18x | 0.70x | 1.47x | |
| Income quality | 1.49x | -0.72x | -0.65x | 59.44x | 6.80x | |
| Graham number | $2 | — | — | $0 | $1 | |
| Graham net-net | -$2 | -$3 | -$2 | -$3 | -$1 | |
| Tax burden | 79.9% | 110.7% | 107.8% | -12171.4% | 80.4% | |
| Interest burden | 87.1% | -126.0% | 901.8% | -0.0% | 25.2% | |
| Working capital | $81.1M | $49.2M | $11.1M | -$18.7M | $14.0M | |
| Invested capital | $441.5M | $408.2M | $381.5M | $375.5M | $418.4M | |
| Return on assets | 17.8% | -27.3% | -12.5% | 0.2% | 1.1% | |
| Operating ROA | 25.0% | 20.0% | 12.6% | 2.9% | 5.0% | |
| Return on tangible assets | 53.7% | -105.0% | -70.5% | 1.7% | 10.6% | |
| Return on equity | 201.6% | 99.6% | 304.9% | 21.0% | 1.9% | |
| Return on invested capital | 21.5% | 21.6% | 13.8% | -396.5% | 4.5% | |
| Return on capital employed | 28.3% | 22.5% | 14.4% | 3.5% | 5.6% | |
| Earnings yield | 3.7% | -4.2% | -3.6% | 0.1% | 0.3% | |
| Free cash flow yield | 5.5% | 3.0% | 2.1% | 6.1% | 2.0% | |
| Capex / Op. cash flow | 0.5% | 1.0% | 11.7% | 11.0% | 11.0% | |
| Capex / Depreciation | 8.4% | 5.6% | 15.6% | 14.9% | 8.8% | |
| Capex / Sales | 0.2% | 0.3% | 1.6% | 2.9% | 2.6% | |
| SG&A / Sales | 32.6% | 32.9% | 31.0% | 38.6% | 21.0% | |
| R&D / Sales | 11.1% | 10.6% | 11.3% | 9.2% | 7.5% | |
| Stock comp / Sales | 12.4% | 10.8% | 6.1% | 14.6% | 1.8% | |
| Intangibles / Total assets | 66.8% | 74.0% | 82.2% | 88.3% | 89.4% | |
| Days sales outstanding | 56d | 53d | 50d | 42d | 53d | |
| Days payables outstanding | 5d | 14d | 19d | 39d | 24d | |
| Operating cycle | 56d | 53d | 50d | 42d | 53d | |
| Cash conversion cycle | 51d | 40d | 31d | 3d | 29d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years